Halozyme Therapeutics, Inc. vs. MeiraGTx Holdings plc Ordinary Shares
HALO
Halozyme Therapeutics, Inc.
$112.45 +2.53%
VS MGTXMeiraGTx Holdings plc Ordinary Shares
$13.00 -1.89%
Halozyme Therapeutics, Inc. (HALO) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| HALO | MGTX | |
|---|---|---|
| Market Cap | $12.76 billion | $1.27 billion |
| Revenue (TTM) | $1.66 billion | $397.50 million |
| Net Income (TTM) | $413.60 million | $78.93 million |
HALO leads on 3 of 3 size & scale factors.
Valuation
| HALO | MGTX | |
|---|---|---|
| P/E Ratio | 32.78 | 14.94 |
| Price / Book | 88.91 | 5.90 |
| Price / Sales | 7.67 | 3.20 |
MGTX leads on 3 of 3 valuation factors.
Profitability
| HALO | MGTX | |
|---|---|---|
| Net Margin | 24.86% | 19.86% |
| Return on Equity | 288.13% | 36.58% |
HALO leads on 2 of 2 profitability factors.
Risk & Sentiment
| HALO | MGTX | |
|---|---|---|
| Short Interest | 9.79% | 0.33% |
MGTX leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, MGTX overview, MGTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.